The results of this study revealed that the density of CD163+ M2 macrophages was significantly higher in tissue samples from patients who had a poor prognosis (P < 0.05) or with lymph node metastasis (P < 0.05). The gene discussed is CD163; the disease is metastatic malignant neoplasm in the lymph nodes.